蒙特罗莎治疗 GLUE
$10.57 +$0.32 (+3.12%)
休市 · Nov 6, 8:10 pm ET · 最新盘后价 $10.57 0.00%
开盘$10.30
昨收$10.25
当日区间$9.88 – $10.67
成交量1.01M
市值$903.21M
市盈率（TTM）–
股息率–
基本面
最新报告季度：Q2, ended Jun 2026
营收$8.97M-61.3% YoY
营业利润-$49.13M-215.9% YoY
净利润-$43.40M-253.0% YoY
摊薄每股收益-$0.43-186.7% YoY
自由现金流-$48.84M-34.1% YoY
经营现金流-$44.11M
营收，近8个季度
净利润，近8个季度
各季度摊薄每股收益
各季度自由现金流
年度营收
盈利能力与资产负债表
营业利润率-633.0%
净利率-560.9%
净资产收益率-42.7%
资产收益率-30.7%
投入资本回报率-42.8%
流动比率10.58
负债/资产比率29.5%
现金及投资$621.10M
总负债$33.36M
净现金（净负债）$587.75M
利润表
| 项目 | 2026 Q2 | 2026 Q1 | 2025 ANNUAL | 2025 Q4 | 2025 Q3 |
|---|---|---|---|---|---|
| 报告营业总收入 | $8.97M | $4.21M | $123.67M | $2.78M | $12.77M |
| 营业总收入 | $8.97M | $4.21M | $123.67M | $2.78M | $12.77M |
| 营业费用 | $58.10M | $54.24M | $177.88M | $52.50M | $45.74M |
| 销售及管理费用 | $10.13M | $10.18M | $36.38M | $10.52M | $9.07M |
| -管理费用 | $10.13M | $10.18M | $36.38M | $10.52M | $9.07M |
| 研发费用 | $47.96M | $44.07M | $141.50M | $41.98M | $36.68M |
| 营业利润 | -$49.13M | -$50.03M | -$54.21M | -$49.72M | -$32.98M |
| 非经营性利息净收入（支出） | $5.92M | $5.59M | $12.94M | $3.69M | $2.75M |
| 非经营性利息收入 | $5.92M | $5.59M | $12.94M | $3.69M | $2.75M |
| 其他收入（支出） | $25,000.00 | -$8,000.00 | $1.54M | -$50,000.00 | -$29,000.00 |
| 证券出售收益 | $25,000.00 | -$8,000.00 | $1.48M | -$50,000.00 | -$29,000.00 |
| 特殊收益（费用） | $0.00 | $0.00 | $59,000.00 | $0.00 | $0.00 |
| -固定资产出售收益 | $0.00 | $0.00 | $59,000.00 | $0.00 | $0.00 |
| 税前利润 | -$43.19M | -$44.45M | -$39.72M | -$46.08M | -$30.26M |
| 税费 | $208,000.00 | $52,000.00 | -$1.10M | $59,000.00 | -$3.18M |
| 净利润 | -$43.40M | -$44.50M | -$38.63M | -$46.14M | -$27.08M |
| 持续经营利润 | -$43.40M | -$44.50M | -$38.63M | -$46.14M | -$27.08M |
| 归属母公司净利润 | -$43.40M | -$44.50M | -$38.63M | -$46.14M | -$27.08M |
| 归属普通股股东净利润 | -$43.40M | -$44.50M | -$38.63M | -$46.14M | -$27.08M |
| 基本每股收益 | -$0.43 | -$0.45 | -$0.46 | -$0.70 | -$0.33 |
| 摊薄每股收益 | -$0.43 | -$0.45 | -$0.46 | -$0.70 | -$0.33 |
资产负债表
| 项目 | 2026 Q2 | 2026 Q1 | 2025 ANNUAL | 2025 Q4 | 2025 Q3 |
|---|---|---|---|---|---|
| 总资产 | $691.16M | $736.43M | $448.66M | $448.66M | $459.84M |
| 流动资产合计 | $631.41M | $677.55M | $393.19M | $393.19M | $401.82M |
| 现金及现金等价物与短期投资 | $621.10M | $666.22M | $377.10M | $377.10M | $391.26M |
| -现金及现金等价物 | $90.10M | $159.86M | $129.88M | $129.88M | $208.34M |
| -短期投资 | $531.00M | $506.36M | $247.22M | $247.22M | $182.92M |
| 应收款 | $4.92M | $4.61M | $11.60M | $11.60M | $4.97M |
| -其他应收款 | $4.92M | $4.61M | $11.60M | $11.60M | $4.97M |
| 其他流动资产 | $5.38M | $6.72M | $4.48M | $4.48M | $5.59M |
| 非流动资产合计 | $59.76M | $58.88M | $55.47M | $55.47M | $58.02M |
| 固定资产净值 | $53.99M | $53.10M | $50.37M | $50.37M | $52.66M |
| -固定资产原值 | $85.54M | $82.75M | $77.99M | $77.99M | $78.19M |
| -累计折旧 | -$31.55M | -$29.64M | -$27.61M | -$27.61M | -$25.52M |
| 其他非流动资产 | $5.77M | $5.78M | $5.10M | $5.10M | $5.36M |
| 负债合计 | $203.88M | $214.51M | $215.60M | $215.60M | $214.00M |
| 流动负债合计 | $59.66M | $71.04M | $64.21M | $64.21M | $61.44M |
| 应付款 | $7.15M | $7.90M | $3.55M | $3.55M | $14.51M |
| -应付账款 | $7.15M | $7.90M | $3.55M | $3.55M | $14.51M |
| 一年内应计费用 | $18.30M | $19.31M | $15.12M | $15.12M | $8.99M |
| 短期债务及融资租赁负债 | $4.63M | $4.48M | $4.40M | $4.40M | $4.24M |
| -一年内到期融资租赁负债 | $4.63M | $4.48M | $4.40M | $4.40M | $4.24M |
| 一年内递延负债 | $22.10M | $33.06M | $29.57M | $29.57M | $24.79M |
| 其他流动负债 | $1.17M | $1.24M | $1.58M | $1.58M | $1.65M |
| 非流动负债合计 | $144.22M | $143.48M | $151.39M | $151.39M | $152.56M |
| 长期债务及融资租赁负债 | $33.36M | $34.58M | $34.79M | $34.79M | $35.93M |
| -长期融资租赁负债 | $33.36M | $34.58M | $34.79M | $34.79M | $35.93M |
| 一年以上递延负债 | $105.62M | $103.64M | $111.33M | $111.33M | $111.89M |
| 员工福利 | $5.24M | $5.26M | $5.27M | $5.27M | $4.74M |
| 股东权益合计 | $487.28M | $521.92M | $233.06M | $233.06M | $245.84M |
| 股东权益 | $487.28M | $521.92M | $233.06M | $233.06M | $245.84M |
| 股本 | $9,000.00 | $8,000.00 | $7,000.00 | $7,000.00 | $6,000.00 |
| -普通股 | $9,000.00 | $8,000.00 | $7,000.00 | $7,000.00 | $6,000.00 |
| -优先股 | $0.00 | $0.00 | – | – | $0.00 |
| 资本公积 | $1.06B | $1.05B | $714.09M | $714.09M | $680.16M |
| 留存收益 | -$565.11M | -$521.72M | -$477.21M | -$477.21M | -$431.08M |
| 不影响留存收益的损益 | -$5.17M | -$4.75M | -$3.83M | -$3.83M | -$3.25M |
| 可转换优先证券 | – | $0.00 | $0.00 | $0.00 | – |
现金流量表
| 项目 | 2026 Q2 | 2026 Q1 | 2025 ANNUAL | 2025 Q4 | 2025 Q3 |
|---|---|---|---|---|---|
| 经营活动现金流 | -$44.11M | -$37.37M | -$22.80M | -$43.01M | $100.43M |
| 持续经营经营活动现金流净额 | -$44.11M | -$37.37M | -$22.80M | -$43.01M | $100.43M |
| 持续经营净利润 | -$43.40M | -$44.50M | -$38.63M | -$46.14M | -$27.08M |
| 折旧、折耗与摊销 | $1.91M | $2.03M | $8.36M | $2.09M | $2.10M |
| 营运资金变动 | -$7.63M | $141,000.00 | -$9.19M | -$3.36M | $121.52M |
| -应收款变动 | -$311,000.00 | $6.99M | -$11.43M | -$6.64M | -$2.60M |
| -预付资产变动 | $1.34M | -$2.92M | $604,000.00 | $1.38M | $941,000.00 |
| -应付账款及应计费用变动 | $717,000.00 | $665,000.00 | -$5.86M | -$1.88M | $13.07M |
| -其他营运资金变动 | -$9.37M | -$4.59M | $7.49M | $3.77M | $110.10M |
| 投资活动现金流净额 | -$28.86M | -$261.00M | -$101.83M | -$65.07M | $38.14M |
| 持续经营投资活动现金流净额 | -$28.86M | -$261.00M | -$101.83M | -$65.07M | $38.14M |
| 固定资产购置及出售净额 | -$4.72M | -$1.87M | -$4.70M | -$767,000.00 | -$651,000.00 |
| 投资购置及出售净额 | -$24.14M | -$259.13M | -$97.13M | -$64.30M | $38.79M |
| 筹资活动现金流 | $3.21M | $328.34M | $30.35M | $29.62M | $348,000.00 |
| 持续经营筹资活动现金流净额 | $3.21M | $328.34M | $30.35M | $29.62M | $348,000.00 |
| 普通股发行净额 | $0.00 | $324.30M | $23.89M | $23.89M | $0.00 |
| 股票期权行使所得 | $3.21M | $4.52M | $6.46M | $5.73M | $348,000.00 |
| 其他筹资费用净额 | $0.00 | -$487,000.00 | – | – | – |
| 期末现金余额 | $95.04M | $164.81M | $134.84M | $134.84M | $213.29M |
| 现金净变动 | -$69.76M | $29.97M | -$94.28M | -$78.46M | $138.91M |
| 期初现金余额 | $164.81M | $134.84M | $229.12M | $213.29M | $74.38M |
| 自由现金流 | -$48.84M | -$39.24M | -$27.50M | -$43.78M | $99.78M |
| 持续经营损益 | – | – | -$59,000.00 | $0.00 | $0.00 |
暂无评论——快来第一个聊聊 GLUE。